CD8A and neoplasm: Moreover, we assessed the impact of SNCP-125I brachytherapy on tumor pathological and tumor immune microenvironment, and found long-term tumor cell necrosis and fibrosis, and increase tumor CD8+T cell infiltration after the treatment.